New Tobacco Cessation Treatment Guidelines Released by VA and DoD
-
By
-
Debbie Bunch
-
October 5, 2026
Clinical Report: New Tobacco Cessation Treatment Guidelines Released by VA and DoD
Overview
The new clinical practice guideline from the VA and DoD includes 32 recommendations for tobacco cessation, emphasizing motivational interviewing and the use of varenicline.
Background
Tobacco use remains a significant health concern, particularly among veterans and military personnel. Effective cessation strategies are crucial for improving health outcomes in these populations. The newly released guidelines provide evidence-based recommendations to support healthcare providers in addressing tobacco dependence.
Data Highlights
The guideline includes 32 recommendations across ten topic areas, focusing on motivational interviewing and pharmacotherapy options.
Key Findings
- Varenicline is recommended over other pharmacologic agents for tobacco cessation.
- NRT monotherapy is not preferred; combination NRT is encouraged.
- Bupropion sustained-release can be used beyond 12 weeks.
- Varenicline is effective for users of smokeless tobacco and ENDS.
- NRT or varenicline can increase quit attempts among patients not ready to quit within 30 days.
Clinical Implications
The guidelines highlight the importance of addressing emerging tobacco products in treatment plans.
Conclusion
The 2026 VA/DoD clinical practice guideline offers evidence-based recommendations for tobacco cessation.
Related Resources & Content
- Department of Veterans Affairs and Department of Defense, Annals of Internal Medicine, 2026 -- Tobacco Use Treatment: Synopsis of the 2026 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
- mdspire news — VA/DoD guideline broadens tobacco treatment
- The ASCO Post — NCCN Publishes New Guidelines for Smoking Cessation Key Points
- ada news — Coalition supports making VA facilities smoke free
- MDSpire News — VA DOD Updates Asthma Framework
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR TOBACCO USE TREATMENT
- Tobacco Use Treatment: Synopsis of the 2026 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR TOBACCO USE TREATMENT
- 'A renewed emphasis on tobacco cessation’ for warfighter readiness - DHA.mil
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR TOBACCO USE TREATMENT
- Recommendation: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
- Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? | Cochrane
- Cytisinicline for Smoking Cessation: A Randomized Clinical Trial | Trials | JAMA | JAMA Network
- Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial | Trials | JAMA Internal Medicine | JAMA Network
- Smoking cessation for people with severe mental illness: systematic review and network meta-analysis | BMJ Medicine
Based on findings from:
VA/DoD Publish New Tobacco Use Treatment Guideline
Debbie Bunch. American Association For Respiratory Care, 2026.
https://rccentral.aarc.org/va-dod-publish-new-tobacco-use-treatment-guideline/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
